日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A real-world comparison of nivolumab plus cabozantinib and pembrolizumab plus lenvatinib focusing on safety outcomes in metastatic renal cell carcinoma: results from the JK-FOOT consortium

一项针对转移性肾细胞癌患者的真实世界研究比较了纳武利尤单抗联合卡博替尼和帕博利珠单抗联合乐伐替尼的安全性结果:来自 JK-FOOT 联盟的研究结果

Yanagisawa, Takafumi; Mori, Keiichiro; Kawada, Tatsushi; Katayama, Satoshi; Tsujino, Takuya; Maenosono, Ryoichi; Toyoda, Shingo; Nukaya, Takuhisa; Morinaka, Hirofumi; Tamura, Keita; Fukuokaya, Wataru; Urabe, Fumihiko; Murakami, Masaya; Bekku, Kensuke; Takahara, Kiyoshi; Fujita, Kazutoshi; Azuma, Haruhito; Araki, Motoo; Inamoto, Teruo; Komura, Kazumasa; Kimura, Takahiro

Comparative efficacy of immune checkpoint inhibitor combination therapies by metastatic site in metastatic renal cell carcinoma

转移性肾细胞癌中免疫检查点抑制剂联合疗法疗效的比较(按转移部位划分)

Toyoda, Shingo; Inoki, Lan; Hashimoto, Mamoru; Fukuokaya, Wataru; Mori, Keiichiro; Nishimura, Shingo; Maenosono, Ryoichi; Iwata, Takehiro; Bekku, Kensuke; Nukaya, Takuhisa; Yanagisawa, Takafumi; Tsujino, Takuya; Komura, Kazumasa; Takahara, Kiyoshi; Inamoto, Teruo; Azuma, Haruhito; Fujita, Kazutoshi

The Prognostic Significance of Radiographic Progression Without PSA Progression in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line ARPI Therapy

一线ARPI治疗治疗转移性激素敏感性前列腺癌患者中,PSA无进展但影像学进展的预后意义

Tsutsumi, Takeshi; Yamazaki, Shogo; Matsuda, Takuya; Tsujino, Takuya; Uchimoto, Taizo; Yanagisawa, Takafumi; Mori, Keiichiro; Fukuokaya, Wataru; Fumihiko Urabe; Saruta, Masanobu; Yoshizawa, Atsuhiko; Toyoda, Shingo; Fujimoto, Saizo; Nishio, Kyosuke; Sakamoto, Moritoshi; Fukushima, Tatsuo; Nakamura, Ko; Nishimura, Kazuki; Nakamori, Keita; Matsunaga, Tomohisa; Yoshikawa, Yuki; Maenosono, Ryoichi; Takahara, Kiyoshi; Inamoto, Teruo; Kimura, Takahiro; Fujita, Kazutoshi; Komura, Kazumasa; Azuma, Haruhito

Exposure to ileal feces with frailty-associated dysbiosis elevates gastrointestinal complication risk after intracorporeal urinary diversion

接触伴有虚弱相关菌群失调的回肠粪便会增加体内尿路改道术后胃肠道并发症的风险。

Zennami, Kenji; Nukaya, Takuhisa; Ishikawa, Kiyohito; Tomozawa, Shuhei; Kawai, Akihiro; Nakamura, Wataru; Muto, Yoshinari; Saruta, Masanobu; Motonaga, Tomonari; Takenaka, Masashi; Takahara, Kiyoshi; Kusaka, Mamoru; Sumitomo, Makoto; Shiroki, Ryoichi

Development and validation of nomograms for predicting pentafecta outcomes before and after robot-assisted radical prostatectomy: a retrospective study

机器人辅助根治性前列腺切除术前后五重结局预测列线图的建立与验证:一项回顾性研究

Bejrananda, Tanan; Takahara, Kiyoshi; Sowanthip, Dutsadee; Motonaga, Tomonari; Yagi, Kota; Nakamura, Wataru; Saruta, Masanobu; Nukaya, Takuhisa; Takenaka, Masashi; Zennami, Kenji; Ichino, Manabu; Sasaki, Hitomi; Sumitomo, Makoto; Shiroki, Ryoichi

Eosinophils as a predictive marker of treatment-related adverse events in mRCC patients treated with first-line immune-checkpoint inhibitor combination therapy

嗜酸性粒细胞作为一线免疫检查点抑制剂联合疗法治疗转移性肾细胞癌患者治疗相关不良事件的预测标志物

Kawada, Tatsushi; Katayama, Satoshi; Yanagisawa, Takafumi; Mori, Keiichiro; Fukuokaya, Wataru; Komura, Kazumasa; Tsujino, Takuya; Maenosono, Ryoichi; Takahara, Kiyoshi; Nukaya, Takuhisa; Inoki, Lan; Toyoda, Shingo; Hashimoto, Takeshi; Hirasawa, Yosuke; Edamura, Kohei; Kobayashi, Tomoko; Bekku, Kensuke; Nishimura, Shingo; Iwata, Takehiro; Sadahira, Takuya; Tominaga, Yusuke; Yamanoi, Tomoaki; Yoshinaga, Kasumi; Tsuboi, Kazuma; Kobayashi, Yasuyuki; Takamoto, Atsushi; Kurose, Kyohei; Kimura, Takahiro; Azuma, Haruhito; Shiroki, Ryoichi; Fujita, Kazutoshi; Ohno, Yoshio; Araki, Motoo

Biochemical recurrence prediction after robot-assited radical prostatectomy (BCR-PRARP)

机器人辅助根治性前列腺切除术后生化复发预测(BCR-PRARP)

Bejrananda, Tanan; Takahara, Kiyoshi; Sowanthip, Dutsadee; Motonaga, Tomonari; Yagi, Kota; Nakamura, Wataru; Saruta, Masanobu; Nukaya, Takuhisa; Takenaka, Masashi; Zennami, Kenji; Ichino, Manabu; Sasaki, Hitomi; Sumitomo, Makoto; Shiroki, Ryoichi

Role of Cytoreductive Nephrectomy in the Immune Checkpoint Inhibitor Era: A Multicenter Collaborative Study

细胞减灭性肾切除术在免疫检查点抑制剂时代的作用:一项多中心合作研究

Nukaya, Takuhisa; Takahara, Kiyoshi; Toyoda, Shingo; Inoki, Lan; Fukuokaya, Wataru; Mori, Keiichiro; Iwata, Takehiro; Bekku, Kensuke; Maenosono, Ryoichi; Tsujino, Takuya; Hirasawa, Yosuke; Yanagisawa, Takafumi; Hashimoto, Takeshi; Komura, Kazumasa; Araki, Motoo; Fujita, Kazutoshi; Ohno, Yoshio; Shiroki, Ryoichi

Impact of Estimated Glomerular Filtration Rate and Serum C-Reactive Protein Level to Overall Survival After Second-Line Targeted Therapy Following Immuno-Oncology Combination Therapy for Advanced Renal Cell Carcinoma

肾小球滤过率和血清C反应蛋白水平对晚期肾细胞癌患者接受免疫肿瘤联合治疗后二线靶向治疗后总生存期的影响

Nakane, Keita; Watanabe, Hiromitsu; Naiki, Taku; Takahara, Kiyoshi; Inamoto, Teruo; Yasui, Takahiro; Shiroki, Ryoichi; Miyake, Hideaki; Koie, Takuya

Cancer-induced Pain Is Associated With Poor Overall Survival of Urothelial Carcinoma Patients Treated With Enfortumab Vedotin

癌症引起的疼痛与接受恩福妥单抗治疗的尿路上皮癌患者的总体生存率较低相关。

Hashimoto, Mamoru; Fukiage, Ken; Taniguchi, Kosei; Minami, Takafumi; Yanagisawa, Takafumi; Fukuokaya, Wataru; Maenosono, Ryoichi; Yoshikawa, Yuki; Tsujino, Takuya; Saruta, Masanobu; Takahara, Kiyoshi; Hirasawa, Yosuke; Hashimoto, Takeshi; Ohno, Yoshio; Kimura, Takahiro; Shiroki, Ryoichi; Fujita, Kazutoshi